Effect of Bifidobacterium breve M-16V Supplementation on Fecal Bifidobacteria in Preterm Neonates - A Randomised Double Blind Placebo Controlled Trial
- 2014-03-03
- RCT · n = 159
- PLoS ONE 9(3)
- S. Patole
- A. Keil
- An-Yi Chang
- E. Nathan
- D. Doherty
- K. Simmer
- Meera Esvaran
- P. Conway
- PubMed: 24594833
- DOI: 10.1371/journal.pone.0089511
10 Insights on
- Increased Fecal Bifidobacteria Levels
- Increased Fecal Bifidobacteria
- Increased Fecal Bifidobacterium breve Levels
- No Adverse Health Effects
- Reduced Incidence of NEC Stage II or Greater
- Reduced NEC Stage II Cases
- Reduced Occurrence of NEC (Bell's Stage 2 or Higher)
- Increased Fecal Bifidobacterium Count
- Prevention of NEC Stage II
- No Significant Increase in Adverse Effects
- High evidence
- Highly Cited
- Rigorous Journal